Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 3 Issue: 4, August

Preface

Volume:3   Issue: 4
Pp: ii-ii
Ajay Gautam
DOI: 10.2174/15680096103030400ii
Published on: 01 March, 2012

Aerosol Therapy for Malignancy Involving the Lungs

Volume:3   Issue: 4
Pp: 239-250
R. D. Rao, S. N. Markovic and P. M. Anderson
DOI: 10.2174/1568009033481895
Published on: 01 March, 2012

Camptothecins and Lung Cancer: Improved Delivery Systems by Aerosol

Volume:3   Issue: 4
Pp: 251-264
N. V. Koshkina, J. C. Waldrep and V. Knight
DOI: 10.2174/1568009033481930
Published on: 01 March, 2012

Targeting the Lung: Preclinical and Comparative Evaluation of Anticancer Aerosols in Dogs with Naturally Occurring Cancers

Volume:3   Issue: 4
Pp: 265-273
Chand Khanna and David M. Vail
DOI: 10.2174/1568009033481903
Published on: 01 March, 2012

The Re-Emergence of Aerosol Gene Delivery: A Viable Approach to Lung Cancer Therapy

Volume:3   Issue: 4
Pp: 275-286
Charles L. Densmore
DOI: 10.2174/1568009033481886
Published on: 01 March, 2012

Paclitaxel (Taxol) and Taxoid Derivates for Lung Cancer Treatment: Potential for Aerosol Delivery

Volume:3   Issue: 4
Pp: 287-296
Ajay Gautam and Nadezhda Koshkina
DOI: 10.2174/1568009033481912
Published on: 01 March, 2012